[_ES5] 英語口演5
新規治療・萌芽的研究

[ES5-3-5] 化学療法中の卵巣予備能・妊孕性温存のための新規治療の開発：ミュラー管抑制因子の応用
Concurrent Mullerian inhibiting Substance therapy during chemotherapy preserves the ovarian reserve and fertility

Motohiro Kano^1,2, Lihua Zhang², Hatice Saatcioglu², Nicholas Nagykery², Tatsuo Kuroda¹, Patricia Donahoe², David Pepin² (1.Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan, 2.Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA United States)